# Ye Xiaoping

Governance Shadow Over China’s CRO Giant: Tigermed Founders Targeted by Regulators

The founders of Tigermed, China's leading clinical CRO, are under investigation by the CSRC for disclosure violations regarding past shareholding changes. Despite a massive 1 billion RMB buyback plan to reassure markets, the company faces significant headwinds including a 70% drop in quarterly net profit.